BioSpace News Archive

Stroudwater Associates, the nation’s leading source of strategic, operational, and financial strategy for rural and community hospitals, announced today it has surpassed its impact goals for 2019 and is positioned for additional growth in 2020.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the European Commission approved Sunosi® (solriamfetol) to improve wakefulness and reduce excessive daytime sleepiness (EDS) in adults with narcolepsy (with or without cataplexy) or obstructive sleep apnea (OSA) whose EDS has not been satisfactorily treated by primary OSA therapy, such as continuous positive airway pressure (CPAP)

Transcenta Holding Limited (“Transcenta”), a global biotherapeutics company with fully-integrated capabilities in discovery, R&D and manufacturing of antibody-based therapeutics, announces today that an investigational new drug (IND) application of its humanized Claudin 18.2 (CLDN18.2) monoclonal antibody (also known as TST001 internally)

Median Technologies (Paris:ALMDT), The Imaging Phenomics Company® announces the publication date for its 2019 results

Recognized for excellent care in the Bloomsburg–Berwick region, The Gardens at Orangeville – a nursing home offering short-term rehabilitation and long-term care services – recently launched a pulmonary rehabilitation program for people who suffer from lung conditions such as asthma, chronic obstructive pulmonary disease (COPD),

Today, 3B Scientific, a portfolio company of J.H. Whitney Capital Partners, LLC and the world’s leading manufacturer and marketer of anatomical models and medical simulation products for healthcare and patient education, announced that it has entered into an agreement to acquire iSimulate Pty. Ltd. (“iSimulate”),

Lexicon Pharmaceuticals, Inc., announced that data from a poster highlighting XERMELO® will be presented at the American Society for Clinical Oncology 2020 Symposium.